Bladder Cancer VL

From Science to Clinical Utility: Cxbladder Monitor- Bladder Cancer Surveillance for Patients with Urothelial Carcinoma - Tamer Aboushwareb, Neal Shore & Josh Meeks

Details
Tamer Aboushwareb, Vice President of Medical Affairs, Pacific Edge, Ltd provides an overview of the Cxbladder Monitor urine-based cancer surveillance test and is joined by Neal Shore and Josh Meeks for a discussion on the clinical implications of the use of this test. Several supportive publications are highlighted and Drs Shore, Meeks, and Aboushwareb discuss the Cxbladder Monitor algorithm, its...

Using Artificial Intelligence (AI) to Identify and Diagnose Bladder Cancer - Hikmat Al-Ahmadie & Olivier Elemento

Details
Hikmat Al-Ahmadie and Olivier Elemento join Ashish Kamat to discuss the data on artificial intelligence in cancer, with specific reference to bladder cancer. The discussion includes an overview of the benefits of using AI and deep machine learning to predict tumor types, responses, and diagnoses. The conversation addresses how automation and digitization intersect well with pathology. However, cur...

MRI Versus Cystoscopic Staging for Newly Diagnosed Bladder Cancer, The BladderPath Trial - Nicholas James

Details
Nicholas James joins Alicia Morgans in a discussion of the first results of the novel BladderPath trial examining the role of magnetic resonance imaging (MRI) for bladder cancer staging. BladderPath is a randomized comparison of the time from the initial diagnosis to “correct” treatment among patients with possible muscle-invasive bladder cancer who receive staging with MRI, compared to TURBT. Nic...

From Science to Clinical Utility: Cxbladder Detect - Bladder Cancer Detection for Patients Who Present with Hematuria - Tamer Aboushwareb, Neal Shore & Josh Meeks

Details
Tamer Aboushwareb, Vice President of Medical Affairs, Pacific Edge, Ltd provides an overview of the Cxbladder Detect urine-based cancer diagnostic test and is joined by Neal Shore and Josh Meeks for a discussion on the clinical implications of the use of this test which is designed for high-risk patients who present with hematuria. Cxbladder is a suite of non-invasive, urine-based laboratory tests...

A Novel Imaging Modality, FAP Imaging for Patients with Bladder Cancer - Vadim S. Koshkin

Details
Petros Grivas and Vadim Koskin discuss an investigator-initiated trial of imaging across solid malignancies. A novel way of imaging cancer. Fibroblast activation protein-α (FAP) is a transmembrane protein overexpressed on cancer-associated fibroblasts (CAFs), and instead of imaging cancer cells themselves, this images cells that are present in cancer. These scans label fibroblast activation protei...

Women in Urologic Oncology - Anne K. Schuckman

Details
Anne Schuckman and Alicia Morgans discuss the unique challenges and opportunities for women in urologic oncology. The two explore their own journeys in the field and provide suggestions on how young women seeking a career in urologic oncology can build their careers with confidence. Biographies: Anne K. Schuckman, MD, Director, LAC+USC Urologic Oncology, Keck Hospital of USC, USC Norris Cancer Hos...

Bladder Cancer Highlights - Stephen Williams

Details
Stephen Williams sits down with Alicia Morgans to share some of the bladder cancer highlights from AUA 2022. Dr. Williams touches on a variety of topics in both muscle-invasive bladder cancer and non-muscle-invasive bladder cancer, including data from the QUILT study at UCLA, a pilot study on a comprehensive geriatric assessment tool at the University of Washington, the importance of psychological...

Bladder Cancer in the Older Adult Population: Special Considerations - Tullika Garg

Details
In this discussion with Ashish Kamat, Tullika Garg presents on bladder cancer in the older adult population. Garg and Kamat discuss special considerations when diagnosing and treating this patient population and the differences in older cancer patients from their younger counterparts, due to geriatric conditions. Garg highlights that patients following cancer treatment, report, they have poorer ph...

Highlighting 25 Years of the International Bladder Cancer Network (IBCN) - Barton Grossman

Details
Barton Grossman joins Ashish Kamat in highlighting the 25th anniversary of the International Bladder Cancer Network (IBCN). The 2022 meeting is being held again in Barcelona, Spain, from September 29 – October 1. Dr. Grossman shares reflections on the cooperative efforts of the Bladder Cancer Marker Network of the National Cancer Institute (NCI), which focuses on developing and assessing biomarker...

Gender Differences in Bladder Cancer - Lauren Cooley

Details
Lauren Cooley joins Alicia Morgans for a discussion on gender differences in bladder cancer. Men are far more likely to be diagnosed with bladder cancer compared to women. Yet when women are diagnosed with bladder cancer, they are usually older and their disease is more advanced. Dr. Cooley explains how her research uses a mouse model to explore potential genetic and immunologic differences in the...
email news signup